SCHEMBL2825592

SCHEMBL2825592

CCOc1cc2c(cc1OC)C(c1ccc(OC)nc1OC)=N[C@@H]1CCCC[C@H]21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 3/20 0.43
PDE4A P27815 2/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
FPR2 P25090 3/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 1/20 0.33
CHRM1 P11229 1/20 0.33
PDE3A Q14432 1/20 0.33
ERN1 O75460 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
MAPK1 P28482 1/20 0.32
CASP1 P29466 1/20 0.32
CTSG P08311 2/20 0.32
KLK7 P49862 2/20 0.32
KLK14 Q9P0G3 2/20 0.32
KLK5 Q9Y337 2/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2851971 0.93 ERN1 (0.36) PDE4DPDE4APDE4BPDE4CKMT2A
SCHEMBL2851968 0.93 ERN1 (0.36) PDE4DPDE4APDE4BPDE4CKMT2A
SCHEMBL2825675 0.93 ERN1 (0.36) PDE4DPDE4APDE4BPDE4CKMT2A
SCHEMBL5124265 0.89 PDE4D (0.36) PDE4DPDE4APDE4BPDE4CERN1
SCHEMBL5116011 0.89 PDE4D (0.36) PDE4DPDE4APDE4BPDE4CERN1
SCHEMBL2266089 0.87 PDE4A (0.41) PDE4DPDE4APDE4BPDE4CFPR2
SCHEMBL1411013 0.87 PDE4D (0.43) PDE4DPDE4APDE4BPDE4CFPR2
SCHEMBL14911084 0.87 PDE4D (0.43) PDE4DPDE4APDE4BPDE4CFPR2
SCHEMBL2267064 0.87 PDE4D (0.43) PDE4DPDE4APDE4BPDE4CFPR2
SCHEMBL1411375 0.87 PDE4D (0.43) PDE4DPDE4APDE4BPDE4CFPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1846390-B1 NOVEL 6-PYRIDYLPHENANTHRIDINES NYCOMED GMBH (DE) 2010-03-17 EP claimed
EP-1846390-B1 NOVEL 6-PYRIDYLPHENANTHRIDINES NYCOMED GMBH (DE) 2010-03-17 EP disclosed
US-20080119505-A1 Novel 6-Pyridylphenanthridines ALTANA PHARMA AG (DE) 2008-05-22 US disclosed
EP-1846390-A1 NOVEL 6-PYRIDYLPHENANTHRIDINES Nycomed GmbH (DE) 2007-10-24 EP disclosed
WO-2006082185-A1 NOVEL 6-PYRIDYLPHENANTHRIDINES NYCOMED GMBH (DE) 2006-08-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119505-A1 Novel 6-Pyridylphenanthridines PDE4A, PDE4B, PDE4C PDE4D 4/4885PDE4A 1/4885PDE4B 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.